Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Express Scripts
Colorcon
Harvard Business School
Medtronic
McKesson
QuintilesIMS
Deloitte

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,610,327

« Back to Dashboard

Which drugs does patent 6,610,327 protect, and when does it expire?

Patent 6,610,327 protects AVELOX and is included in one NDA.

This patent has forty-six patent family members in thirty-nine countries.
Summary for Patent: 6,610,327
Title: Pharmaceutical moxifloxacin preparation
Abstract:The present invention relates to a pharmaceutical preparation for oral administration which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its preparation, and to the use of this preparation for controlling bacterial infections in humans and animals.
Inventor(s): Bosche; Patrick (Odenthal, DE), Mahler; Hans Friedrich (Koln, DE), Weisemann; Claus (Apex, NC)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:09/830,770
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Formulation; Use;

Drugs Protected by US Patent 6,610,327

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bayer Hlthcare AVELOX moxifloxacin hydrochloride TABLET;ORAL 021085-001 Dec 10, 1999 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y METHOD OF COMBATING BACTERIA IN A PATIENT ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,610,327

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany198 55 758Nov 10, 1998
PCT Information
PCT FiledOctober 29, 1999PCT Application Number:PCT/EP99/08230
PCT Publication Date:May 18, 2000PCT Publication Number: WO00/27398

International Patents Family Members for US Patent 6,610,327

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1149993 ➤ Try a Free Trial
Colombia 5070571 ➤ Try a Free Trial
Cuba 23260 ➤ Try a Free Trial
Czech Republic 20011652 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Fish and Richardson
Baxter
Federal Trade Commission
Farmers Insurance
Colorcon
Harvard Business School
Boehringer Ingelheim
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.